TRACY ENNIS: Open Payments
NPI 1003121609 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$749 in 30 payments from 13 companies in 2025. Trend: 2023 $639 · 2024 $683 · 2025 $749
Food & beverage: $749
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $150 |
| Janssen Biotech, Inc. | 9 | $144 |
| Regeneron Healthcare Solutions, Inc. | 3 | $98 |
| ABBVIE INC. | 4 | $80 |
| Lilly USA, LLC | 3 | $68 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $49 |
| GENZYME CORPORATION | 1 | $39 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Arcutis Biotherapeutics, Inc. | 1 | $23 |
| UCB, Inc. | 1 | $22 |
Products named: Sotyktu, TREMFYA, SKYRIZI, DUPIXENT, TALTZ, LIBTAYO, ILUMYA, COSENTYX.
Industry payments across FL — which companies pay providers there.
